The new asthma Cardiff University discovery is possibly the largest breakthrough in science in a long time, as it not only uncovers the way the chronic inflammatory disease works, but it also means potentially finding the cure for the an illness that haunts millions around the world.

There are a few particular illnesses that are potentially deadly, such as cancer and AIDS, and there have been many efforts on the part of scientists to find different kinds of cures for both of them, as well as preventing them from occurring - but, as the asthma Cardiff University discovery goes to show, that hasn't meant other terrible diseases have been left outside the field of scientific investigation.

Asthma is a chronic inflammatory illness that includes a wide array of respiratory problems such as coughing, chest tightness, shortness of breath and wheezing in the least grave symptoms, and others like airflow obstruction and bronchospasm in more serious cases - but the new asthma Cardiff University study could mean a complete eradication of all levels of the illness.

According to The Telegraph, the new asthma Cardiff University discovery also comes hand in hand with the Kings College London, as a group of researches identified particularly which cells cause airways to narrow after being trigged by pollution and other irritants - in all, the cause for asthma.

BBC reports that the asthma Cardiff University researchers have proven that CaSR (calcium sensing receptor) is the one that causes asthma - and this discovery, in turn, has showed which existing drug could potentially treat patients of the illness: calcilytics.

According to The Daily Mail, while the better part of asthma patients (a worldwide amount of about 300 million) can usually be treated with inhalers, there's a small percentage of those who have asthma, 5 percent, that doesn't really respond to any treatment.

"Our findings are incredibly exciting," said Professor Daniela Riccardi, one of the Cardiff University researchers. "If we can prove that calcilytics are safe when administered directly to the lung in people, then in five years we could be in a position to treat patients and potentially stop asthma from happening in the first place."